Sonologie science

10/21/2026

A groundbreaking treatment pairing auditory tones with mild electrical shocks rewires the brain to quiet chronic tinnitus.

Chronic tinnitus, the agonizing perception of ringing in the ears without an external sound source, affects millions worldwide and has long eluded effective medical intervention.

However, innovative research in neuroscience shows that bimodal neuromodulation—a technique combining audio tones with gentle electrical stimulation delivered directly to the tongue—can effectively quiet these phantom sounds.

By stimulating touch receptors on the tongue while simultaneously playing targeted acoustic signals through headphones, the treatment leverages the brain's natural neuroplasticity. This dual-sensory approach encourages the central nervous system to reframe its sensory processing, essentially retraining the brain to ignore hyperactive auditory signals.

In a landmark clinical study involving over 300 adults suffering from chronic subjective tinnitus, more than 86% of compliant participants experienced a significant reduction in symptom severity following 12 weeks of daily treatment.

Remarkably, these therapeutic benefits persisted for up to 12 months post-treatment, representing a major leap forward in long-term tinnitus care. Described by patients as feeling like a mild fizzing sensation on the tongue, this non-invasive therapy offers a promising and safe alternative to traditional management strategies, bringing renewed hope to millions seeking lasting relief.

source: Conlon, B., Langguth, B., Hamilton, C., Hughes, S., Meade, E., Connor, C. O., Schecklmann, M., Hall, D. A., Toal, P. D., & Lim, H. H.. Bimodal neuromodulation combining sound and tongue stimulation reduces tinnitus symptoms in a large randomized clinical study. Science Translational Medicine, 12(564).

10/18/2026

10/17/2026

Stanford's Sound Wave Therapy Dissolves Brain Tumors Non-Invasively
American doctors dissolved brain tumors using focused sound waves without any surgery today. Brain surgery without a single cut. Stanford doctors are dissolving brain tumors using focused ultrasound, beams of sound so precise they can destroy a tumor through the intact skull. No incision. No anesthesia. No hospital stay. Patients walk in, receive treatment, and walk out. The future of brain surgery is sound 🔊.

The technique is called focused ultrasound. Hundreds of ultrasound beams converge on the tumor from different angles, each too weak to harm tissue on its own. At the focal point, they combine into a powerful hot spot that heats and destroys the tumor cells. It is like using a magnifying glass to focus sunlight, but with sound and millimeter precision. Real-time MRI guides the beams, letting doctors watch the tumor dissolve live. Surrounding brain tissue is untouched. 🧠

The impact is profound. Brain surgery is among the riskiest procedures in medicine. Opening the skull carries infection risk, long recovery, and potential damage to healthy brain. Focused ultrasound eliminates all of that. It is already being tested for glioblastoma, the deadliest brain tumor, and for tremor and Parkinson's. For patients too frail for surgery, it offers a lifeline that did not exist before.

Sound is invisible, painless, and powerful. Medicine is learning to aim it like a scalpel. The operating room of the future may have no blades at all. Hospitals around the world are now installing focused ultrasound systems for brain treatment. Would you let sound waves operate on your brain?

Source: Stanford Medicine, 2025

10/16/2026

Send a message to learn more

10/16/2026

A cancer treatment invented at the University of Michigan is being hailed as one of the most significant non-invasive breakthroughs in oncology in decades.

Histotripsy uses focused ultrasound waves to mechanically destroy tumor tissue without a single incision, drug or beam of radiation. The technique was invented at U-M in 2002 by researchers including Zhen Xu, a professor of biomedical engineering.

The method works by generating microsecond-long pulses of sound that create tiny bubbles inside the tumor. Those bubbles expand and contract, putting mechanical stress on the tissue until the cancer cells break apart.

In October 2023, the FDA approved histotripsy for liver tumors, clearing it for use in humans through HistoSonics, a company co-founded in 2009 by University of Michigan engineers and doctors. Thousands of patients have since been treated, with trials now underway for kidney and prostate cancers.

Researchers have also found that even partial destruction of a tumor can matter. Doctoral student Tejaswi Worlikar said histotripsy “can overcome the limitations of currently available ablation modalities and provide safe and effective noninvasive liver tumor ablation.”

This September, the university opened a new $10 million Histotripsy Center, funded by HistoSonics, Michigan Engineering and private donors, to expand the technology into other cancers including thyroid, pancreas, breast, prostate, brain, skin and sarcoma. A separate neuro program is working to adapt the technique for brain diseases.

The center will also open its equipment to outside researchers at no cost. Xu said her hope is that the center will bring histotripsy “to a wide scientific community and eventually to all clinicians and patients.”

Leaders of the program believe the technology could eventually lead to additional FDA approvals and reach hundreds of thousands of patients within five years.

10/11/2026

Sonologie 2017 Emmanuel, le Bourdon de Notre Dame. Le son d'Emmanue...

10/11/2026

10/11/2026